tiprankstipranks
Actinium Pharmaceuticals (ATNM)
:ATNM
US Market
ATNM
Actinium Pharmaceuticals
RESEARCH TOOLSreports
Want to see ATNM full AI Analyst Report?

Actinium Pharmaceuticals (ATNM) Income Statement

2,277 Followers

Actinium Pharmaceuticals Income Statement

Last quarter (Q1 2026), Actinium Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Actinium Pharmaceuticals's net income was $-5.52M. See Actinium Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 90.00K$ 0.00$ 81.00K$ 1.03M$ 1.14M
Gross Profit
$ 90.00K$ -811.00K$ 81.00K$ 1.03M$ 620.00K
Operating Expenses
$ 36.34M$ 41.31M$ 52.00M$ 35.13M$ 25.58M
Depreciation and Amortization
$ 821.00K$ 811.00K$ 790.00K$ 699.00K$ 524.00K
EBITDA
$ -35.43M$ -37.43M$ -51.13M$ -33.41M$ -24.25M
Operating Income
$ -36.25M$ -42.12M$ -51.92M$ -34.10M$ -24.96M
Other Income/Expenses
$ 2.36M$ 3.88M$ 3.10M$ 1.09M$ 190.00K
Pretax Income
$ -33.89M$ -38.24M$ -48.82M$ -33.02M$ -24.77M
Net Income
$ -33.89M$ -38.24M$ -48.82M$ -33.02M$ -24.77M
Per Share Metrics
Basic EPS
$ -1.09$ -1.27$ -1.83$ -1.37$ -1.20
Diluted EPS
$ -1.09$ -1.27$ -1.83$ -1.37$ -1.20
Weighted Average Shares Outstanding
 31.20M 30.07M 26.60M 24.14M 20.57M
Weighted Average Shares Outstanding (Diluted)
 31.20M 30.07M 26.60M 24.14M 20.57M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History